XM does not provide services to residents of the United States of America.
G
G

Grifols

Technical Summary

IndicatorValueTrend
IndicatorValueTrend
IndicatorValueTrend
IndicatorS3S2S1PR1R2R3

News

Gigagen Awarded U.S. Barda Contract To Develop Recombinant Polyclonal Antibody Therapies

BRIEF-Gigagen Awarded U.S. Barda Contract To Develop Recombinant Polyclonal Antibody Therapies Oct 3 (Reuters) - Gigagen: AWARDED U.S. BARDA CONTRACT TO DEVELOP RECOMBINANT POLYCLONAL ANTIBODY THERAPIES FOR BOTULINUM NEUROTOXINS AND AN ADDITIONAL BIOTHREAT CONTRACT TO PROVIDE INITIAL COMMITMENT OF $19.6 MILLION AND UP TO $135.2 MILLION OVER SIX-YEA
G

Spanish stocks - Factors to watch on Oct 1

Spanish stocks - Factors to watch on Oct 1 Oct 1 (Reuters) - The following Spanish stocks may be affected by newspaper reports and other factors on Tues day . Reuters has not verified the newspaper reports, and cannot vouch for their accuracy: INDRA IDR.MC Indra said on Monday it plans to start a formal process in order to examine various options related to its unit Minsait Payments.
A
G
H
N
S
T
I
S

Brookfield reaffirms its interest in Grifols, ask more time for analysis, sources say

Brookfield reaffirms its interest in Grifols, ask more time for analysis, sources say By Andres Gonzalez LONDON, Sept 30 (Reuters) - Canadian fund Brookfield BN.TO reaffirmed its interest in a potential takeover of Spanish drugmaker Grifols GRLS.MC and requested more time to complete due diligence for its possible bid, two sources with knowledge of the matter said on Monday.
G

Grifols plans to invest $402 million in new industrial centre, El Economista says

Grifols plans to invest $402 million in new industrial centre, El Economista says Sept 30 (Reuters) - Spanish drugmaker Grifols GRLS.MC plans to invest 360 million euros ($401.98 million) to build a new industrial plant in Barcelona for its engineering department, newspaper El Economista said on Monday, citing unidentified company sources. Grifols is seeking to centralise operations currently dispersed across different locations, El Economista said.
G

Spanish stocks - Factors to watch on Sept 30

Spanish stocks - Factors to watch on Sept 30 Sept 30 (Reuters) - The following Spanish stocks may be affected by newspaper reports and other factors on Monday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy: AYCO ALCE.SCT Ayco said on Friday the final result of its share capital increase amounted to 6 million euros ($6.70 million).
G
S

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.